Close Menu
    What's Hot

    Editor’s Letter – Volume 2, Issue 5, May 2026

    May 13, 2026

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

      April 22, 2026

      Daiichi Life to Reinsure Whole Life Block with Prismic Life

      April 13, 2026

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains

      April 22, 2026

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026
      Just Group

      Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

      May 11, 2026

      Bakkavor Pension Scheme Completes Bulk Purchase Annuity Buy-In With Rothesay

      May 5, 2026
      Bank of England

      Prudential Regulation Authority Publishes New Funded Reinsurance Regulations

      April 29, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026

      UK Equity Release Market Origination Slows To Begin 2026

      May 6, 2026

      CHIP Mortgage Trust Issues C$200m of Medium-Term Notes

      April 29, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Caveat Emptor: Life Settlements and the Natural Person Exemption From Licensure

    Secondary Life Markets February 8, 2023By James Maxson
    Litigation
    Share
    Twitter LinkedIn Email

    Interest in the life settlement asset class, the purchase of an unwanted and unneeded life insurance policy for a lump sum payment, has continued to grow steadily over the course of the last two decades because of potential double digit returns uncorrelated to the capital markets. The foundation for investors’ confidence in the asset class is that the policies purchased are legally originated and will not be subject to challenge by the policies’ former owners or beneficiaries. A recent decision from a federal court in Texas calls into question the viability of an often-used exemption from licensure and emphasizes how important it is that investors carefully diligence the policies they purchase, or risk losing their entire investment.

    Stakeholders and investors in the life settlements market know that to purchase a life insurance policy from a non-terminally ill owner, it is necessary to have a “provider’s” license in 43 of the 50 states. These licenses are time consuming and expensive to obtain, and their maintenance entails significant on-going compliance obligations. Thus, it is no surprise that providers who have invested years and tens of thousands of dollars in time and money into procuring and maintaining these licenses take umbrage with individuals and companies who regularly rely on the so-called “natural person” exemption from licensure to purchase policies.

    This exemption, which is found in both the National Association of Insurance Commissioners’ (“NAIC”) and National Council of Insurance Legislators’ (“NCOIL”) model acts, typically reads along the lines of the following:

    “Settlement provider” does not include: A natural person who enters into or effectuates no more than one agreement in a calendar year for the transfer of life insurance policies.

    According to the Proceedings of the NAIC, when it adopted its model settlement act in 1993, the intent of including the “natural person” exemption was “to exclude from the Act a friend or family member of the policyholder who wanted to enter into an agreement with a [policy owner][,]”  because, “it would create a hardship to subject family and friends to the model act.” 1993 Proc. 3rd Quarter 439.  Hence, the intent of the NAIC in adopting the exemption was clear – to exclude a person with a close relationship to a policy owner from the burdensome obligations associated with provider licensure.

    In contravention of the explicit intent of the NAIC, some participants in the life settlements industry have taken this exemption for use by a friend or family member and turned it into a business model, allowing them to act as a provider without having to shoulder the burden and expense of obtaining providers’ licenses. This is the fact pattern that the court confronted recently in Consolidated Wealth Management, LLC v. Short, 414 F.Supp.3d 1011 (S.D. Tex. 2019).

    In January 2014, James Short, a resident of West Virginia, entered into a Senior Facilitation Agreement (“SFA”) with an individual employee of Montage Financial Group (“Montage”). Montage played no role in the transaction with Mr. Short and was not a party to the SFA. Under the terms of the SFA, Mr. Short agreed to assign his interest in the policy for a payment of $25,016. Three days after entering the SFA with Mr. Short, the individual assigned his entire interest in the policy to Consolidated Wealth Management (“CWM”) for a payment of $37,700.

    On June 22, 2018, Mr. Short passed away. Mrs. Short thereafter filed a claim for the death benefit under the policy, and CWM made a competing claim. As a result, the carrier filed an interpleader action.

    The parties’ arguments were straightforward. Mrs. Short contended that the sale of her husband’s policy violated West Virginia’s viatical settlement law, and was, therefore, unlawful and void.  Whereas, CWM argued that under the “natural person” exemption in West Virginia’s law, the individual who purchased the policy was not a “viatical settlement provider” when he entered into the SFA and therefore the SFA is not a “viatical settlement contract” under West Virginia law.

    Even though the court found that the individual who purchased Mr. Short’s policy had only entered into a single settlement contract in the pertinent year, it nevertheless ruled in favor of Mrs. Short.  The court’s reasoning was founded on a common-sense interpretation of the language of the statute.

    It was the uncontroverted testimony of the individual that he, through Montage, had been involved in approximately 75 viatical settlements in 2014 and a “bit less” in 2013. The court noted that the “statute excepts from coverage persons who neither enter into more than one viatical settlement contract nor effectuate more than one such contract in a year. A person must meet both conditions to be excluded from the Act’s scope.” 414 F.Supp.3d at 1018-19. The court rejected the argument that the only operative language was “enters into” and ruled that the individual had clearly “effectuated” far more than one contract in his work at Montage.

     The court also rejected CWM’s argument that the exception applies to persons who regularly effectuate settlement contracts so long as they contract with only a single West Virginia resident in a calendar year, finding that the “exception only covers ‘an individual who enters into or effectuates no more than one viatical settlement contract in a calendar year,’ without regard to the viator’s state of residence.”  Id.

    As a result, the court effectively unwound the sale transaction and awarded the entire death benefit to Mrs. Short. 

    While this appears to be a case of first impression, it is possible other courts faced with similar facts will reach the same conclusion. Therefore, investors in the life settlements asset class would be wise to deal only with licensed life settlement providers, and not individuals who improperly utilize the natural person exemption from licensing to purchase policies.

    Finally, it is worth noting that state insurance departments currently do not appear to be aware of the extent to which this exemption is utilized by individuals to skirt the licensing rules or is used by otherwise licensed providers to purchase policies in states where they are not licensed. If state regulators do become aware of the extensive use, and arguable abuse, of the exemption it is likely regulatory consequences will follow.

    James W. Maxson is a Founding Partner at Edwards Maxson Mago & Macaulay, LLP


    Any views expressed in this article are those of the author(s) and do not necessarily reflect the views of Life Risk News or its publisher, the European Life Settlement Association.

    Commentary Life Settlements Longevity Risk Volume 2 Issue 2 - February 2023
    Share. Twitter LinkedIn Email

    Related Posts

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026By Greg Winterton

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026By Dr. Jyotsna Kamble
    Just Group

    Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

    May 11, 2026By LMI Newsdesk

    UK Equity Release Market Origination Slows To Begin 2026

    May 6, 2026By LMI Newsdesk
    Latest Issue

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.